AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $469,485 | +37.0% | 411,829 | +9.9% | 0.00% | – |
| Q2 2023 | $342,781 | -5.0% | 374,624 | -41.8% | 0.00% | – |
| Q1 2023 | $360,962 | +83.4% | 644,117 | +88.8% | 0.00% | – |
| Q4 2022 | $196,832 | +78.9% | 341,129 | -1.8% | 0.00% | – |
| Q3 2022 | $110,000 | -52.6% | 347,518 | -47.1% | 0.00% | – |
| Q2 2022 | $232,000 | -67.5% | 656,539 | -34.1% | 0.00% | – |
| Q1 2022 | $714,000 | -73.6% | 995,714 | -16.8% | 0.00% | – |
| Q4 2021 | $2,703,000 | -36.3% | 1,196,214 | -18.8% | 0.00% | -100.0% |
| Q3 2021 | $4,244,000 | -57.9% | 1,473,505 | -44.6% | 0.00% | 0.0% |
| Q2 2021 | $10,083,000 | -10.8% | 2,660,373 | -20.4% | 0.00% | -50.0% |
| Q1 2021 | $11,308,000 | +1451.2% | 3,340,710 | +1182.3% | 0.00% | – |
| Q4 2020 | $729,000 | -75.8% | 260,517 | -78.3% | 0.00% | -100.0% |
| Q3 2020 | $3,014,000 | +3.4% | 1,201,256 | +459.7% | 0.00% | 0.0% |
| Q2 2020 | $2,914,000 | +116.5% | 214,622 | +21.0% | 0.00% | – |
| Q1 2020 | $1,346,000 | -78.4% | 177,382 | -82.0% | 0.00% | -100.0% |
| Q4 2019 | $6,231,000 | +55.9% | 986,035 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $3,998,000 | -31.6% | 1,019,670 | -15.6% | 0.00% | -50.0% |
| Q2 2019 | $5,849,000 | -46.2% | 1,208,391 | -9.0% | 0.00% | -33.3% |
| Q1 2019 | $10,873,000 | +90.2% | 1,327,528 | +28.4% | 0.00% | +50.0% |
| Q4 2018 | $5,717,000 | -65.7% | 1,033,908 | -45.2% | 0.00% | -50.0% |
| Q3 2018 | $16,666,000 | +20.0% | 1,887,436 | +35.7% | 0.00% | 0.0% |
| Q2 2018 | $13,887,000 | +24.1% | 1,391,367 | +18.5% | 0.00% | +33.3% |
| Q1 2018 | $11,186,000 | -1.9% | 1,173,863 | +53.1% | 0.00% | 0.0% |
| Q4 2017 | $11,403,000 | -18.6% | 766,888 | +7.7% | 0.00% | -25.0% |
| Q3 2017 | $14,012,000 | +38.8% | 712,372 | +1.4% | 0.00% | +33.3% |
| Q2 2017 | $10,097,000 | -37.0% | 702,705 | -59.6% | 0.00% | +50.0% |
| Q1 2017 | $16,016,000 | -5.6% | 1,740,884 | +6.8% | 0.00% | -33.3% |
| Q4 2016 | $16,968,000 | +455.6% | 1,630,146 | +383.0% | 0.00% | +200.0% |
| Q3 2016 | $3,054,000 | +84.4% | 337,506 | +52.4% | 0.00% | 0.0% |
| Q2 2016 | $1,656,000 | -21.4% | 221,505 | -5.2% | 0.00% | 0.0% |
| Q1 2016 | $2,106,000 | +64.5% | 233,748 | +135.8% | 0.00% | – |
| Q4 2015 | $1,280,000 | +17.3% | 99,146 | -12.2% | 0.00% | – |
| Q3 2015 | $1,091,000 | +120.0% | 112,909 | +134.3% | 0.00% | – |
| Q2 2015 | $496,000 | -20.0% | 48,187 | -13.7% | 0.00% | – |
| Q1 2015 | $620,000 | -56.9% | 55,825 | -54.8% | 0.00% | -100.0% |
| Q4 2014 | $1,438,000 | -78.6% | 123,535 | -59.2% | 0.00% | -66.7% |
| Q3 2014 | $6,704,000 | -39.2% | 302,912 | -23.7% | 0.00% | -25.0% |
| Q2 2014 | $11,028,000 | – | 396,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |